These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

219 related items for PubMed ID: 30887517

  • 1. Targeted therapy of the AKT kinase inhibits esophageal squamous cell carcinoma growth in vitro and in vivo.
    Liu X, Song M, Wang P, Zhao R, Chen H, Zhang M, Shi Y, Liu K, Liu F, Yang R, Li E, Bode AM, Dong Z, Lee MH.
    Int J Cancer; 2019 Aug 15; 145(4):1007-1019. PubMed ID: 30887517
    [Abstract] [Full Text] [Related]

  • 2. Ursolic Acid Accelerates Paclitaxel-Induced Cell Death in Esophageal Cancer Cells by Suppressing Akt/FOXM1 Signaling Cascade.
    Meng RY, Jin H, Nguyen TV, Chai OH, Park BH, Kim SM.
    Int J Mol Sci; 2021 Oct 25; 22(21):. PubMed ID: 34768915
    [Abstract] [Full Text] [Related]

  • 3. Isoliquiritigenin Suppressed Esophageal Squamous Carcinoma Growth by Blocking EGFR Activation and Inducing Cell Cycle Arrest.
    Ye L, Zhang J, Zhang Y, Gu B, Zhu H, Mao X.
    Biomed Res Int; 2020 Oct 25; 2020():9259852. PubMed ID: 32190688
    [Abstract] [Full Text] [Related]

  • 4. Potential therapeutic effect of targeting glycogen synthase kinase 3β in esophageal squamous cell carcinoma.
    Bolidong D, Domoto T, Uehara M, Sabit H, Okumura T, Endo Y, Nakada M, Ninomiya I, Miyashita T, Wong RW, Minamoto T.
    Sci Rep; 2020 Jul 16; 10(1):11807. PubMed ID: 32678196
    [Abstract] [Full Text] [Related]

  • 5. Deoxypodophyllotoxin, a Lignan from Anthriscus sylvestris, Induces Apoptosis and Cell Cycle Arrest by Inhibiting the EGFR Signaling Pathways in Esophageal Squamous Cell Carcinoma Cells.
    Kwak AW, Lee MH, Yoon G, Cho SS, Choi JS, Chae JI, Shim JH.
    Int J Mol Sci; 2020 Sep 18; 21(18):. PubMed ID: 32961992
    [Abstract] [Full Text] [Related]

  • 6. Scutellarin Suppresses Patient-Derived Xenograft Tumor Growth by Directly Targeting AKT in Esophageal Squamous Cell Carcinoma.
    Liu F, Zu X, Xie X, Zhang Y, Liu K, Chen H, Wang T, Bode AM, Dong Z, Kim DJ.
    Cancer Prev Res (Phila); 2019 Dec 18; 12(12):849-860. PubMed ID: 31554627
    [Abstract] [Full Text] [Related]

  • 7. Plumbagin inhibits the proliferation and survival of esophageal cancer cells by blocking STAT3-PLK1-AKT signaling.
    Cao YY, Yu J, Liu TT, Yang KX, Yang LY, Chen Q, Shi F, Hao JJ, Cai Y, Wang MR, Lu WH, Zhang Y.
    Cell Death Dis; 2018 Jan 16; 9(2):17. PubMed ID: 29339720
    [Abstract] [Full Text] [Related]

  • 8. Dracorhodin perchlorate induces apoptosis and G2/M cell cycle arrest in human esophageal squamous cell carcinoma through inhibition of the JAK2/STAT3 and AKT/FOXO3a pathways.
    Lu Z, Lu C, Li C, Jiao Y, Li Y, Zhang G.
    Mol Med Rep; 2019 Sep 16; 20(3):2091-2100. PubMed ID: 31322237
    [Abstract] [Full Text] [Related]

  • 9. Luteolin enhances drug chemosensitivity by downregulating the FAK/PI3K/AKT pathway in paclitaxel‑resistant esophageal squamous cell carcinoma.
    Yang Z, Liu H, Song Y, Gao N, Gao P, Hui Y, Li Y, Fan T.
    Int J Mol Med; 2024 Sep 16; 54(3):. PubMed ID: 38994756
    [Abstract] [Full Text] [Related]

  • 10. Xanthohumol Inhibits the Growth of Keratin 18-Overexpressed Esophageal Squamous Cell Carcinoma in vitro and in vivo.
    Yin S, Song M, Zhao R, Liu X, Kang WK, Lee JM, Kim YE, Zhang C, Shim JH, Liu K, Dong Z, Lee MH.
    Front Cell Dev Biol; 2020 Sep 16; 8():366. PubMed ID: 32509787
    [Abstract] [Full Text] [Related]

  • 11. Targeting AKT with Oridonin Inhibits Growth of Esophageal Squamous Cell Carcinoma In Vitro and Patient-Derived Xenografts In Vivo.
    Song M, Liu X, Liu K, Zhao R, Huang H, Shi Y, Zhang M, Zhou S, Xie H, Chen H, Li Y, Zheng Y, Wu Q, Liu F, Li E, Bode AM, Dong Z, Lee MH.
    Mol Cancer Ther; 2018 Jul 16; 17(7):1540-1553. PubMed ID: 29695636
    [Abstract] [Full Text] [Related]

  • 12. SOX2 promotes tumor growth of esophageal squamous cell carcinoma through the AKT/mammalian target of rapamycin complex 1 signaling pathway.
    Gen Y, Yasui K, Nishikawa T, Yoshikawa T.
    Cancer Sci; 2013 Jul 16; 104(7):810-6. PubMed ID: 23510069
    [Abstract] [Full Text] [Related]

  • 13. Pristimerin exhibits anti-cancer activity by inducing ER stress and AKT/GSK3β pathway through increasing intracellular ROS production in human esophageal cancer cells.
    Hu WB, Liu YT, Li J, Wang Y, Sun XZ, Hua MY, Liu XT, Hui BN.
    Toxicol In Vitro; 2024 Aug 16; 99():105867. PubMed ID: 38848824
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Plumbagin, a natural naphthoquinone, inhibits the growth of esophageal squamous cell carcinoma cells through inactivation of STAT3.
    Cao Y, Yin X, Jia Y, Liu B, Wu S, Shang M.
    Int J Mol Med; 2018 Sep 16; 42(3):1569-1576. PubMed ID: 29901084
    [Abstract] [Full Text] [Related]

  • 18. Dexrazoxane inhibits the growth of esophageal squamous cell carcinoma by attenuating SDCBP/MDA-9/syntenin-mediated EGFR-PI3K-Akt pathway activation.
    Du R, Xiao N, Han L, Guo K, Li K, Chen Z, Zhang H, Zhou Z, Huang Y, Zhao X, Bian H.
    Sci Rep; 2024 Apr 22; 14(1):9167. PubMed ID: 38649770
    [Abstract] [Full Text] [Related]

  • 19. A dual mTORC1 and mTORC2 inhibitor shows antitumor activity in esophageal squamous cell carcinoma cells and sensitizes them to cisplatin.
    Huang Y, Xi Q, Chen Y, Wang J, Peng P, Xia S, Yu S.
    Anticancer Drugs; 2013 Oct 22; 24(9):889-98. PubMed ID: 23838676
    [Abstract] [Full Text] [Related]

  • 20. Dandelion root extract affects ESCC progression via regulating multiple signal pathways.
    Duan X, Pan L, Deng Y, Liu Y, Han X, Fu H, Li Y, Li M, Wang T.
    Food Funct; 2021 Oct 04; 12(19):9486-9502. PubMed ID: 34476429
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.